Skip to main content
. Author manuscript; available in PMC: 2021 Oct 29.
Published in final edited form as: Pediatr Blood Cancer. 2020 Jul 7;67(9):e28529. doi: 10.1002/pbc.28529

FIGURE 2.

FIGURE 2

Plasma angiogenic biomarkers before and on treatment. Angiopoietin-2 (ANG2) levels (A), angiopoietin-1 (ANG1) (B), soluble vascular endothelial growth factor receptor 3 (sVEGFR3) (C), and ratio of ANG2/ANG1 (D) were measured by multiplex in plasma from age and sec-matched controls (open circles) and the KLA patient at diagnosis (black circles) and over the treatment course as indicated along x-axis. Normal reference ranges are indicated by gray shading